PeptideDB

CW069 1594094-64-0

CW069 1594094-64-0

CAS No.: 1594094-64-0

CW069 (CW-069; CW 069) is a potent, selective and allosteric inhibitor of microtubule motor protein HSET with potential
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

CW069 (CW-069; CW 069) is a potent, selective and allosteric inhibitor of microtubule motor protein HSET with potential antitumor activity. It inhibits HSET with an IC50 of 75 μM.


Physicochemical Properties


Molecular Formula C23H21IN2O3
Molecular Weight 500.33
Exact Mass 500.059
CAS # 1594094-64-0
Related CAS #
1594094-64-0
PubChem CID 73427517
Appearance White to off-white solid powder
Density 1.6±0.1 g/cm3
Boiling Point 666.0±55.0 °C at 760 mmHg
Flash Point 356.6±31.5 °C
Vapour Pressure 0.0±2.1 mmHg at 25°C
Index of Refraction 1.687
LogP 6.74
Hydrogen Bond Donor Count 3
Hydrogen Bond Acceptor Count 4
Rotatable Bond Count 8
Heavy Atom Count 29
Complexity 532
Defined Atom Stereocenter Count 1
SMILES

C1=CC=C(C=C1)C[C@@H](C(=O)NC2=C(C=C(C=C2)I)C(=O)O)NCC3=CC=CC=C3

InChi Key IRDIXDXDSUBHIU-NRFANRHFSA-N
InChi Code

InChI=1S/C23H21IN2O3/c24-18-11-12-20(19(14-18)23(28)29)26-22(27)21(13-16-7-3-1-4-8-16)25-15-17-9-5-2-6-10-17/h1-12,14,21,25H,13,15H2,(H,26,27)(H,28,29)/t21-/m0/s1
Chemical Name

5-Iodo-2-[[(2S)-1-oxo-3-phenyl-2-[(phenylmethyl)amino]propyl]amino]-benzoic acid
Synonyms

CW069; CW-069; CW 069
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro CW-069 is an HSET allosteric inhibitor, with an IC50 of 75 μM. Selectivity over KSP that is statistically significant is demonstrated by CW-069. CW-069 exhibits a robust suppressive effect on N1E-115 cells and a less potent inhibitory effect on NHDF cells, with IC50 values of 86 ± 10 μM and 181 ± 7 μM, respectively. When applied in N1E-115 cells with supernumerary centrosomes, CW-069 (100 or 200 μM) increases multipolar spindles, but it has no effect on the shape of bipolar spindles in normal human dermal fibroblast cells. While CW-069 (200 μM) inhibits monastrol's suppression of KSP and causes multipolar anaphase and cell death in N1E-115 cells transfected with HSET siRNA, it does not cause mitotic arrest in HeLa cells[1].
ln Vivo

Animal Protocol


References

[1]. Design, synthesis, and biological evaluation of an allosteric inhibitor of HSET that targets cancer cells with supernumerary centrosomes. Chem Biol. 2013 Nov 21;20(11):1399-410.


Solubility Data


Solubility (In Vitro)
DMSO:100 mg/mL (199.9 mM)
Water:<1 mg/mL
Ethanol:4 mg/mL (8.0 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.08 mg/mL (4.16 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.08 mg/mL (4.16 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.08 mg/mL (4.16 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 1.9987 mL 9.9934 mL 19.9868 mL
5 mM 0.3997 mL 1.9987 mL 3.9974 mL
10 mM 0.1999 mL 0.9993 mL 1.9987 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.